Clinical Trial Update: Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing hepatic arterial infusion of sodium bicarbonate combined with the NASOX regimen and PD-1 inhibitors for pancreatic cancer with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• PD-1 inhibitors
• Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Ruijin Hospital | Conditions: Pancreatic Neoplasms, Hepatic Metastasis of Pancreatic Cancer | Phase 2 | Status: RECRUITING